Copenhagen’s Biograil Raises €20 Million for Oral Drug Device
Copenhagen-based Biograil has secured €20 million in funding to develop an oral drug delivery device. This device is designed as an alternative to injections, aiming to improve patient comfort and compliance. The funding will support further development and commercialization of this innovative medical technology.
EU-Startups··Copenhagen




